Market revenue in 2022 | USD 59.3 million |
Market revenue in 2030 | USD 97.4 million |
Growth rate | 6.4% (CAGR from 2022 to 2030) |
Largest segment | Estrogen and progesterone replacement therapy |
Fastest growing segment | Parathyroid Hormone replacement |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 57.84% in 2022. Horizon Databook has segmented the UAE hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.
Hormonal replacement therapy market in the UAE is expected t o exhibit lucrative market growth over the forecast period. The market growth can be attributed to increased awareness about target diseases, availability of hormone replacement therapy treatment, and rising geriatric population.
According to National Library of Medicine (July 2020) , around 41% of women used Menopausal Hormonal Therapy (MHT) t o treat symptoms, 45% of women said MHT was a good treatment, and 2 5% had a negative response regarding the use of MHT in Abu Dhabi, UAE.
In addition, women between the ages o f 4 5 and 5 5 experience menopause. According to World Bank Data (2020), i n the UAE, there are around 41,966 women aged 65 and above. Thus, rising geriatric women population is anticipated to increase the prevalence o f menopause, thereby driving market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into UAE hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account